A significant decrease in cell death time to 13 hours in all human glioblastoma cells analyzed in vitro was observed in this study using a combination of CT, a proteasome inhibitor drug, and a STAT3/5 inhibitor. The gene discussed is STAT3; the disease is glioblastoma.